Navigation Links
Ultragenyx Appoints Tom Kassberg as Chief Business Officer and Announces Management Team
Date:11/21/2011

NOVATO, Calif., Nov. 21, 2011 /PRNewswire/ -- Ultragenyx Pharmaceutical, Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that Tom Kassberg has joined the company as Chief Business Officer. Mr. Kassberg will be responsible for leading the company's business development and corporate strategic planning activities, as well as the human resources and legal affairs functions. Mr. Kassberg brings to Ultragenyx more than twenty years of experience in the pharmaceutical and biotechnology industries.

Before joining Ultragenyx, Mr. Kassberg consulted with Corium International, Inc. and Rib-X Pharmaceuticals, Inc., and previously served as Executive Vice President of Corporate Development at Proteolix, Inc.  He has also held management positions at InterMune, Inc., Plexxikon, Inc. (a company he co-founded), and SUGEN, Inc.  Mr. Kassberg started his career at Bristol-Myers Squibb where he held a variety of positions in finance, product and market analysis, and sales. Mr. Kassberg received his M.B.A. from the Kellogg Graduate School of Management at Northwestern University and his B.A. from Gustavus Adolphus College in Minnesota.

"Tom joins Ultragenyx at an exciting time in our company's growth, as our clinical pipeline is advancing and expanding, and our talented management team is in place," said Emil D. Kakkis, M.D., Ph.D., Chief Executive Officer of Ultragenyx. "Tom brings to Ultragenyx a wealth of industry and operational experience and a successful track record of value-creating transactions that will help Ultragenyx become a successful biopharmaceutical business."

The appointment of Mr. Kassberg complements the Ultragenyx management team, which is comprised of rare disease development experts with broad experience in early-stage as well as established pharmaceutical companies. The management team includes the following key management personnel:


    SOURCE Ultragenyx Pharmaceutical, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Ultragenyx Granted Orphan Drug Designation for UX001 SA-ER for the Treatment of Hereditary Inclusion Body Myopathy (HIBM)
    2. Ultragenyx Initiates Phase 1 Clinical Study of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Muscle Wasting Disease
    3. CVS Caremark Appoints Kevin Murphy President of Accordant Business
    4. Valeant Pharmaceuticals Appoints Howard B. Schiller as Chief Financial Officer
    5. Adeona Appoints Jeff Lucero Riley as Independent Chairman
    6. Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation
    7. InterMune Appoints Angus C. Russell to Board of Directors
    8. Volcano Corporation Appoints Leslie V. Norwalk and Dr. Eric J. Topol to Board of Directors
    9. Vanda Pharmaceuticals Appoints Chief Commercial Officer
    10. Cardica Appoints Christopher Littel VP, Sales and Marketing
    11. S1 Pharmaceuticals Appoints Robert Taylor Segraves, MD, PhD, and Robert Pyke, MD, PhD to Its Scientific Advisory Board
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/21/2014)... - The Canadian Epilepsy Alliance (CEA) is thrilled to announce ... children about the most common neurological disorder in ... comic series tells a fictional story based on the experiences ... with epilepsy. "Despite the fact that epilepsy ... misinformation and lack of awareness out there," says Gail ...
    (Date:8/21/2014)... , Aug. 21, 2014  IBM (NYSE: IBM ... ( DESY ), a leading national research center in ... and storage of massive volumes of x-ray data. The ... on IBM software defined technology can handle more than ... and help scientists worldwide gain faster insights into the ...
    (Date:8/21/2014)... , Aug. 21, 2014  Zacks.com announces the list of ... Equity Research analysts discuss the latest news and events impacting ... blog include the Hewlett-Packard (NYSE: HPQ - Free Report ), ... Inc. (NYSE: SB - Free Report ), GlaxoSmithKline plc ... N.V. (NYSE: FI - Free Report ). ...
    Breaking Medicine Technology:Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11
    (Date:8/22/2014)... FL (PRWEB) August 22, 2014 This ... cell therapy research affiliate, Saneron CCEL Therapeutics, Inc. in ... , “Cryo-Cell is extremely pleased to collaborate with Saneron ... IND, which we hope will lead to regenerative ... diseases such as ALS,” David Portnoy, Chairman and Co-CEO ...
    (Date:8/22/2014)... 2014 (HealthDay News) -- The air in American cities ... Agency reported Thursday. Significant progress has been made ... in recent decades, the agency said in a news ... 60 percent reduction in mercury from human sources such ... and an 84 percent fall in lead, which harms ...
    (Date:8/22/2014)... may reduce addiction without increasing exposure to toxic ... University of Waterloo. , The study published ... the smoking behaviours of 72 adults as they ... reduced nicotine levels. , Unlike when smokers switch ... similar levels of nicotine contentthe study found no ...
    (Date:8/22/2014)... (PRWEB) August 22, 2014 Goats are taking ... Milk Foods, attends the 10th annual Pre-Emmy Awards Boom Boom ... to try the best new products for kids on August ... 4 p.m., and we’ll be encouraging them to #GoGoat for ... so excited to present our gentle, non-GMO goat milk foods ...
    (Date:8/22/2014)... (PRWEB) August 22, 2014 For the ... employee reward and recognition industry, has received a prestigious ... extraordinary growth rate of 134%, TharpeRobbins remains on the ... North America. TharpeRobbins was previously on the list in ... to be included in this distinguished list for a ...
    Breaking Medicine News(10 mins):Health News:Cryo-Cell Provides Funding for Cord Blood Clinical Trial Application to Treat ALS 2Health News:Cryo-Cell Provides Funding for Cord Blood Clinical Trial Application to Treat ALS 3Health News:Air in U.S. Cities Getting Cleaner, EPA Says 2Health News:Smokers consume same amount of cigarettes regardless of nicotine levels 2Health News:#GoGoat with Kabrita at the Pre-Emmy Awards Boom Boom Room 2Health News:For The Fourth Time - TharpeRobbins Earns A Place On Prestigious Inc. Magazine 500|5000 List 2Health News:For The Fourth Time - TharpeRobbins Earns A Place On Prestigious Inc. Magazine 500|5000 List 3
    ... July 9, 2009 The President of the ... statement today on President Obama,s nomination of Francis Collins, M.D., ... Health (NIH):,"At no other time in recent memory has there ... in the power of science to deliver solutions to the ...
    ... Bioheart, Inc. (OTC Bulletin Board: BHRT) (the "Company") ... July 7, 2009, Bioheart, Inc. (the "Company") has received proceeds ... common stock and warrants under its current offering under Regulation ... Common Stock to be issued in connection with the Offering ...
    ... Parsippany took top honors in the state,s first-ever 100-day ... on June 2nd. With participating residents losing an average of ... pounds, Parsippany was presented with a plaque and Morris County ... , Residents throughout northern and central New Jersey also participated ...
    ... , ... and Directory Helps Attendees and Exhibitors,Connect at AAMSE Conference and Beyond. , ... Arlington, VA (PRWEB) July 9, 2009 -- MarketArt ... enhanced attendee experience at the American Association of Medical Society Executives (AAMSE) 2009 ...
    ... Institute of Technology (Caltech) and the Scripps Research Institute have ... chemicals that have the potential to take the place of ... James R. Heath, the Elizabeth W. Gilloon Professor and ... M. Keck Professor of Chemistry at the Scripps Research Institute ...
    ... United States Senate Committee on Small Business ... Member Olympia J. Snowe, R-Maine, today convened a ... relate to small businesses. Participants at the roundtable, ... the Perspective of Small Businesses," included U.S. Sen. ...
    Cached Medicine News:Health News:Bioheart, Inc. Announces Receipt of $2.8 Million in Proceeds From Pipe Financing 2Health News:Bioheart, Inc. Announces Receipt of $2.8 Million in Proceeds From Pipe Financing 3Health News:Parsippany Takes Top Honors in New Jersey's First-Ever Toxic Waistlines Contest 2Health News:Parsippany Takes Top Honors in New Jersey's First-Ever Toxic Waistlines Contest 3Health News:MarketArt to Enhance Attendee Experience at AAMSE Annual Conference 2Health News:MarketArt to Enhance Attendee Experience at AAMSE Annual Conference 3Health News:Caltech chemists say antibody surrogates are just a 'click' away 2Health News:Caltech chemists say antibody surrogates are just a 'click' away 3Health News:Landrieu, Snowe Convene Roundtable on Healthcare for Small Businesses 2Health News:Landrieu, Snowe Convene Roundtable on Healthcare for Small Businesses 3
    Nature's Remarkable Skin Protector -- Karaya 5 is a natural skin barrier that is particularly well suited for skin problems or for sensitive skin where reactions may have occurred to other types of s...
    Protects skin from corrosive drainage with the standard wear, FlexWear skin barrier. Security and confidence assured with porous tape, internal non-reflux valves, convenient drain valve....
    Inquire...
    Inquire...
    Medicine Products: